Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Vericel Corp
Soleus Capital Master Fund, L.P. updated its beneficial ownership stake in Vericel Corp (VCEL) via a Schedule 13G/A filing submitted on August 13, 2026. This filing serves as a routine disclosure regarding changes in the holdings of a major shareholder.…more
Vericel Corp
Kevin F. McLaughlin, an executive at Vericel Corp, filed an SEC Form 144 on August 12, 2026, to report a proposed sale of company securities. This filing serves as a formal notification of the insider's intent to dispose of shares.…more
Vericel Corp
Vericel Corp의 임원 Michael Halpin이 2026년 8월 3일 자사주와 관련된 지분 변동을 신고했습니다. 해당 공시는 Form 4를 통해 내부자의 주식 보유 현황 변경을 공식적으로 보고한 것입니다.…more
7 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Vericel to Report Third Quarter 2026 Financial Results on November 5
Vericel Corporation announced it will report its financial results for the third quarter of 2026 on November 5, 2026. Management will host a conference call to discuss the company's financial performance and business highlights.…more
●●●●●●●● ●●●●● ●●●●●●
Vericel Corporation announced it will present at the 24th Annual Morgan Stanley Global Healthcare Conference on September 15, 2026. This event serves as a standard investor relations activity to provide updates on the company's business.…more
●●●●●●●● ●●●●● ●●●●●●
베리셀은 2분기 매출이 전년 동기 대비 22% 증가하는 등 견조한 실적을 기록하며 연간 매출 전망치를 상향 조정했습니다. 또한, 경영진은 향후 성장성에 대한 자신감을 바탕으로 2억 달러 규모의 자사주 매입 프로그램을 발표했습니다.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.